126 related articles for article (PubMed ID: 17293494)
21. Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen.
Das A; Smalheiser NR; Markaryan A; Kaplan A
Biochim Biophys Acta; 2002 Jul; 1571(3):225-38. PubMed ID: 12090937
[TBL] [Abstract][Full Text] [Related]
22. Domain 5 of high molecular weight kininogen inhibits collagen-mediated cancer cell adhesion and invasion in association with α-actinin-4.
Hatoh T; Maeda T; Takeuchi K; Ogikubo O; Uchiyama S; Otsuka T; Ohkubo I; Ogita H
Biochem Biophys Res Commun; 2012 Oct; 427(3):497-502. PubMed ID: 23000411
[TBL] [Abstract][Full Text] [Related]
23. Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen.
Chavakis T; Kanse SM; Pixley RA; May AE; Isordia-Salas I; Colman RW; Preissner KT
FASEB J; 2001 Nov; 15(13):2365-76. PubMed ID: 11689462
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
Pehrsson S; Johansson K; Kjaer M; Elg M
Thromb Haemost; 2010 Dec; 104(6):1242-9. PubMed ID: 20806126
[TBL] [Abstract][Full Text] [Related]
25. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
[TBL] [Abstract][Full Text] [Related]
26. High-molecular-weight kininogen preadsorbed to glass surface markedly reduces neutrophil adhesion.
Yung LY; Lim F; Khan MM; Kunapuli SP; Rick L; Colman RW; Cooper SL
Biomaterials; 2000 Feb; 21(4):405-14. PubMed ID: 10656323
[TBL] [Abstract][Full Text] [Related]
27. Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.
Heeb MJ; Marzec U; Gruber A; Hanson SR
Thromb Haemost; 2012 Apr; 107(4):690-8. PubMed ID: 22370911
[TBL] [Abstract][Full Text] [Related]
28. Fibrin-rich and platelet-rich thrombus formation on neointima: recombinant tissue factor pathway inhibitor prevents fibrin formation and neointimal development following repeated balloon injury of rabbit aorta.
Asada Y; Hara S; Tsuneyoshi A; Hatakeyama K; Kisanuki A; Marutsuka K; Sato Y; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1998 Sep; 80(3):506-11. PubMed ID: 9759635
[TBL] [Abstract][Full Text] [Related]
29. Domain 5 of cleaved high molecular weight kininogen inhibits endothelial cell migration through Akt.
Katkade V; Soyombo AA; Isordia-Salas I; Bradford HN; Gaughan JP; Colman RW; Panetti TS
Thromb Haemost; 2005 Sep; 94(3):606-14. PubMed ID: 16268479
[TBL] [Abstract][Full Text] [Related]
30. Antithrombin-heparin covalent complex: a possible alternative to heparin for arterial thrombosis prevention.
Chan AK; Rak J; Berry L; Liao P; Vlasin M; Weitz J; Klement P
Circulation; 2002 Jul; 106(2):261-5. PubMed ID: 12105168
[TBL] [Abstract][Full Text] [Related]
31. Fine mapping of the sequences in domain 5 of high molecular weight kininogen (HK) interacting with heparin and zinc.
Pixley RA; Lin Y; Isordia-Salas I; Colman RW
J Thromb Haemost; 2003 Aug; 1(8):1791-8. PubMed ID: 12911595
[TBL] [Abstract][Full Text] [Related]
32. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
Baglia FA; Walsh PN
Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
[TBL] [Abstract][Full Text] [Related]
33. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
[TBL] [Abstract][Full Text] [Related]
34. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
[TBL] [Abstract][Full Text] [Related]
35. Deletion mutagenesis of high molecular weight kininogen light chain. Identification of two anionic surface binding subdomains.
Kunapuli SP; DeLa Cadena RA; Colman RW
J Biol Chem; 1993 Feb; 268(4):2486-92. PubMed ID: 8428925
[TBL] [Abstract][Full Text] [Related]
36. RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model.
Cadroy Y; Houghten RA; Hanson SR
J Clin Invest; 1989 Sep; 84(3):939-44. PubMed ID: 2760221
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor.
Pakala R; Liang CT; Benedict CR
Thromb Res; 2000 Oct; 100(1):89-96. PubMed ID: 11053621
[TBL] [Abstract][Full Text] [Related]
38. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
39. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
[TBL] [Abstract][Full Text] [Related]
40. Combined administration of barbourin--albumin and hirudin--albumin fusion proteins limits fibrin(ogen) deposition on the rabbit balloon-injured aorta.
Sheffield WP; Gataiance S; Eltringham-Smith LJ
Thromb Res; 2007; 119(2):195-207. PubMed ID: 16478628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
